Carillon Tower Advisers’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$6.87M Sell
196,772
-16,236
-8% -$561K 0.04% 372
2020
Q3
$7.39M Sell
213,008
-17,440
-8% -$581K 0.1% 291
2020
Q2
$7.54M Sell
230,448
-116,682
-34% -$3.72M 0.06% 327
2020
Q1
$10.4M Sell
347,130
-40,230
-10% -$1.2M 0.1% 265
2019
Q4
$11.2M Sell
387,360
-15,050
-4% -$417K 0.07% 316
2019
Q3
$10.4M Sell
402,410
-48,324
-11% -$1.22M 0.07% 327
2019
Q2
$11.5M Sell
450,734
-16,888
-4% -$417K 0.08% 324
2019
Q1
$12.2M Sell
467,622
-25,406
-5% -$624K 0.09% 306
2018
Q4
$11.4M Sell
493,028
-93,990
-16% -$2.09M 0.1% 289
2018
Q3
$13.8M Sell
587,018
-63,756
-10% -$1.56M 0.1% 291
2018
Q2
$15M Buy
650,774
+33,756
+5% +$802K 0.12% 260
2018
Q1
$15.2M Buy
+617,018
New +$16.2M 0.12% 240

Other funds holding NVO